Critical Review of Risk Assessment Tools in Pharmaceutical Quality by Design
Palak Karia1★, Anita Ayre1, Asrin Khan1★ Corresponding author
- 1Department of Quality Assurance, Vivekanand Education Society’s College of Pharmacy (Autonomous), Chembur, Maharashtra, INDIA.
CORRESPONDENCE
Palak Karia
Department of Quality Assurance, Vivekanand Education Society’s College of Pharmacy (Autonomous), Chembur, Maharashtra, INDIA.
Received: 11-12-2023; Revised: 22-03-2024; Accepted: 22-08-2024.
Volume 58, Issue 4S · pp. s1145–s1155 · PUBLISHED 2024 · DOI: 10.5530/ijper.58.4s.113
ABSTRACT
Pharmaceutical Quality by Design is a systematic approach to product development that starts with specified objectives and emphasizes product knowledge, methodologies, and operational procedures. It is based on trustworthy science and excellent risk reduction. Risk analysis is a beneficial science-based approach that may assist in discovering the material properties and production variables that may have an impact on the critical quality attributes of the finished product when it comes to high-quality risk management. An active pharmaceutical quality system comprises quality risk management nineteen. It can offer a pro-active strategy for identifying, objectively assessing, and managing possible quality issues. Throughout the course of the product’s lifetime, it enables ongoing better performance results and product quality enhancement. This review article discusses various Quality by Design methodologies for risk assessment during research and development.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Karia, P., Ayre, A., & Khan, A. (2024). Critical Review of Risk Assessment Tools in Pharmaceutical Quality by Design. Indian Journal of Pharmaceutical Education and Research, 58(4S), s1145–s1155. https://doi.org/10.5530/ijper.58.4s.113